Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the pricing of its underwritten public ...

Apple analysts are starting to wonder how much time the iPhone maker has to find an AI strategy before its core business ...